Etanercept therapy in children with juvenile rheumatoid arthritis

Journal of Microbiology, Immunology and Infection

Volumn 38, Issue 6, 2005, Pages 444-446

  Hung, Jeng Juh ^a   Huang, Jing Long ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Etanercept; Juvenile rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; PREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MALE; SCHOOL CHILD; SEIZURE; UPPER RESPIRATORY TRACT INFECTION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; C-REACTIVE PROTEIN; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; RESPIRATORY TRACT INFECTIONS; SEIZURES;

EID: 33344473073     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Peterson LS, Mason T, Nelson AM, O'Fallon WM, Gabriel SE. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? Arthritis Rheum 1996;39:1385-90.
2. Wu CJ, Huang JL, Yang MH, Yan DC, Ou LS, Ho HH. Clinical characteristics of juvenile rheumatoid arthritis in Taiwan. J Microbiol Immunol Infect 2001;34:211-4.
3. Grom AA, Murray KJ, Luyrink L, Emery H, Passo MH, Glass DN, et al. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum 1996;39:1703-10.
4. Ou LS, See LC, Wu CJ, Kao CC, Lin YL, Huang JL. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis. Clin Rheumatol 2002;21:52-6.
5. Huang JL. Methotrexate in the treatment of children with chronic arthritis-long-term observations of efficacy and safety. Br J Clin Prac 1996;50:311-4.
6. Huang JL, Chen LC. Sulphasalazine in treatment of children with chronic arthritis. Clin Rheumatol 1998;17:359-63.
7. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, et al. Protection against a lethal dose of endotoxin by an inhibitor or tumor nectosis factor processing. Nature 1994;370:218-20.
8. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-61.
9. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with poly articular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763-9.
10. Kietz DA, Pepmueller PH, Moore TL. Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two years period. Ann Rheum Dis 2002;61:171-3.
11. Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, et al; Pediatric Rheumatology Collaborative Study Group. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 2003;48:218-26.
12. Russo RA, Katsicas MM, Zelazko M. Etanercept in systemic juvenile idiopathic arthritis. Clin Exp Rheumatol 2002;20:723-6.
13. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003;48:1093-101.
14. Phillips K, Husni ME, Karlson EW, Coblyn JS. Experience with etanercept in an academic medical center: are infection rates increased? Arthritis Rheum 2002;47:17-21.
15. Moreland LW, Bucy RP, Weinblatt ME, Mohler KM, Spencer-Green GT, Chatham WW. Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 2002;103:13-21.